Immunome Inc (IMNM) is a biotechnology company listed on US.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
Use this IMNM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IMNM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IMNM SEC filings page. Lician reads the product cache first so this HTML stays unique to Immunome Inc even when a live quote feed is slow.
Latest cached year on this hub. Full IMNM income, balance, and cash tables.